Inherited cardiomyopathies include hypertrophic cardiomyopathy, dilated cardiomyopathy,
arrhythmogenic right ventricular cardiomyopathy, left ventricular noncompaction, and …

… The principle genetic causes of DCM have been reported in sequencing studies of
moderate-sized cohorts (n≈300) comprised of both familial and sporadic cases. These studies …

Background Cardiac muscle hypercontractility is a key pathophysiological abnormality in
hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow tract (…

Background Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations
in many genes. TTN, the gene encoding the sarcomere protein titin, has been insufficiently …

Importance Genetic testing is a valuable tool for managing inherited cardiovascular disease
in patients and families, including hypertrophic, dilated, and arrhythmogenic …

Background Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed
substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways …

… ); 9% had a variant of unknown significance (SARC VUS, n=253). Forty-five percent had
negative genetic testing results (SARC−, n=1231). The median age at diagnosis was 13.6 years …

… Mutations in both groups were predominantly truncating and predicted to result in allelic
loss of function through nonsense mediated RNA decay (DSP n=105, PKP2 n=81). Genetic …

… (n = 55) with TTN -truncating variants detected in our study (n = 18). The NHLBI ESP cohorts
(~6,500 individuals of European or African-American ancestry) served as a control cohort, …

… (A) Geometric mean of N-terminal pro–B-type natriuretic peptide (NT-proBNP) over time …
Lakdawala has received consulting fees/honorarium from MyoKardia, Inc. Dr. Marian has …